TRIAL DATA
COMMIT trial analysis examines chemoimmunotherapy in dMMR metastatic CRCA new analysis explores what the COMMIT trial can and cannot tell us about combining chemotherapy with immunotherapy in patients with deficient DNA mismatch repair metastatic colorectal cancer. (Journal of Clinical Oncology)